Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,673 | -31,751 | -15,506 | -47,599 | -34,772 |
| Depreciation Amortization | 1,114 | 673 | 306 | 862 | 558 |
| Income taxes - deferred | 86 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 610 | 29 | 603 | -179 | 489 |
| Other Working Capital | -1,379 | -5,070 | -3,101 | -1,099 | -1,429 |
| Other Operating Activity | 5,002 | 3,698 | 1,288 | 6,656 | 4,108 |
| Operating Cash Flow | $-43,240 | $-32,421 | $-16,410 | $-41,359 | $-31,046 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,523 | -1,229 | -504 | -3,879 | -3,060 |
| Purchase Of Investment | -162,147 | -63,005 | -47,956 | -126,261 | -126,534 |
| Sale Of Investment | 109,916 | 80,975 | 30,617 | 109,725 | 82,990 |
| Investing Cash Flow | $-54,754 | $16,741 | $-17,843 | $-20,415 | $-46,604 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 742 | 310 | 185 | 391 | 299 |
| Other Financing Activity | 133,570 | -231 | -135 | 79,132 | 79,121 |
| Financing Cash Flow | $134,312 | $79 | $50 | $79,523 | $79,420 |
| Beginning Cash Position | 65,713 | 65,713 | 65,713 | 47,964 | 47,964 |
| End Cash Position | 102,031 | 50,112 | 31,510 | 65,713 | 49,734 |
| Net Cash Flow | $36,318 | $-15,601 | $-34,203 | $17,749 | $1,770 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,240 | -32,421 | -16,410 | -41,359 | -31,046 |
| Capital Expenditure | -2,523 | -1,229 | -504 | -3,879 | -3,060 |
| Free Cash Flow | -45,763 | -33,650 | -16,914 | -45,238 | -34,106 |